📰 Current Reports News
Page 4 - Current Reports News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Current Reports. Real-time updates on events, politics, business and more.
May 28, 2024
Mr. Coop brings more than 30 years of Operations, Product and Revenue ExpertiseFRAMINGHAM, Mass., May 28, 2024 -- Definitive Healthcare Corp. , an industry leader in healthcare commercial...
May 28, 2024
MIAMI, May 28, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that
May 27, 2024
GREEN COVE SPRINGS, Fla. - MDWerks, Inc. , a forward-thinking company leading the charge in the world of sustainable technology, today announced that its common stock has transitioned to trading on...
May 24, 2024
SALT LAKE CITY, May 23, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and its collaborators will share data from seven
May 23, 2024
Consistent with short-term studies, KarXT was not associated with clinically meaningful changes in movement disorder scale scores and a low incidence rate of extrapyramidal symptoms was reported over...
May 23, 2024
Leapmotor International Begins Operations to Expand Global Electric Vehicle Sales Starting September 2024 in Nine European Countries, Followed by Other Key Growth Regions
May 23, 2024
Company Overview May 23, 2024 Except for the historical information contained herein, certain matters in this presentation...
May 23, 2024
LivaNova PLC , a market-leading medical technology company, today announced Vladimir Makatsaria, Chief Executive Officer, will present in a fireside chat at the Goldman Sachs Healthcare Conference in Miami, Florida. The presentation will take place...
May 23, 2024
NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), an authority in wellness solutions for people on the go, today announced plans to
May 23, 2024
Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data across its oncology and hematology portfolio at the upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting